drugset / Trial / NCT01973933

Clinical Trial to Investigate the Pharmacokinetic/Pharmacodynamic Drug-Drug Interaction of Pyrimethamine and Metformin IR

NCT01973933

Phase 1 Completed 20 enrolled Seoul National University Hospital
NaSingle-groupOpen-labelTreatment

Summary

This study aims to investigate the pharmacokinetic/pharmacodynamic drug-drug interaction of pyrimethamine and metformin IR after oral administration in healthy male volunteers.

Timeline

Start
2013-06
Primary completion
2013-08
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 500 mg Oral
Subject Metformin Small molecule 750 mg Oral
Subject pyrimethamine Small molecule 50 mg Oral

Indications

No indication recorded.